Search

Your search keyword '"Dennison, E M"' showing total 372 results
Start Over Author "Dennison, E M"
372 results on '"Dennison, E M"'

16. Self-perception of fracture risk: what can it tell us?

Author

Litwic, A. E., Compston, J. E., Wyman, A., Siris, E. S., Gehlbach, S. H., Adachi, J. D., Chapurlat, R., Díez-Pérez, A., LaCroix, A. Z., Nieves, J. W., Netelenbos, J. C., Pfeilschifter, J., Rossini, M., Roux, C., Saag, K. G., Silverman, S., Watts, N. B., Greenspan, S. L., March, L., Gregson, C. L., Cooper, C., Dennison, E. M., and Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators

Published
2017
Full Text
View/download PDF

17. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review

Author

Beaudart, C., Dawson, A., Shaw, S. C., Harvey, N. C., Kanis, J. A., Binkley, N., Reginster, J. Y., Chapurlat, R., Chan, D. C., Bruyère, O., Rizzoli, R., Cooper, C., Dennison, E. M., Adib, G., Brandi, M. L., Chevalley, T., Clark, P., Dawson-Hughes, B., El Maghraoui, A., Engelke, K., Fielding, R., Foldes, A. J., Gugliemi, G., Kaufman, J. M., Larijani, B., Lems, W., van Loon, L. J. C., Lyritis, G. P., Maggi, S., Masi, L., McCloskey, E., Messina, O. D., Papaioannou, A., Szulc, P., Veronese, N., and the IOF-ESCEO Sarcopenia Working Group

Published
2017
Full Text
View/download PDF

19. The relationship between maternal self-efficacy, compliance and outcome in a trial of vitamin D supplementation in pregnancy

Author

Barker, M., D’Angelo, S., Ntani, G., Lawrence, W., Baird, J., Jarman, M., Vogel, C., Inskip, H., Cooper, C., Harvey, N. C., Bishop, N. J., Kennedy, S., Papageorghiou, A. T., Schoenmakers, I., Fraser, R., Gandhi, S. V., Carr, A., Crozier, S. R., Moon, R. J., Arden, N. K., Dennison, E. M., Godfrey, K. M., Prentice, A., Mughal, M. Z., Eastell, R., Reid, D. M., Javaid, M. K., and the MAVIDOS Study Group

Published
2017
Full Text
View/download PDF

23. Multimodal multidisciplinary management of patients with moderate to severe pain in knee osteoarthritis:a need to meet patient expectations

Author

Veronese, N. (Nicola), Cooper, C. (Cyrus), Bruyère, O. (Olivier), Al-Daghri, N. M. (Nasser M.), Branco, J. (Jaime), Cavalier, E. (Etienne), Cheleschi, S. (Sara), da Silva Rosa, M. C. (Mario Coelho), Conaghan, P. G. (Philip G.), Dennison, E. M. (Elaine M.), de Wit, M. (Maarten), Fioravanti, A. (Antonella), Fuggle, N. R. (Nicholas R.), Haugen, I. K. (Ida K.), Herrero-Beaumont, G. (Gabriel), Honvo, G. (Germain), Laslop, A. (Andrea), Matijevic, R. (Radmila), Migliore, A. (Alberto), Mobasheri, A. (Ali), Pelletier, J.-P. (Jean-Pierre), Prieto Yerro, M. C. (María Concepción), Radermecker, R. P. (Régis Pierre), Rannou, F. (François), Rizzoli, R. (René), Reginster, J.-Y. (Jean-Yves), Veronese, N. (Nicola), Cooper, C. (Cyrus), Bruyère, O. (Olivier), Al-Daghri, N. M. (Nasser M.), Branco, J. (Jaime), Cavalier, E. (Etienne), Cheleschi, S. (Sara), da Silva Rosa, M. C. (Mario Coelho), Conaghan, P. G. (Philip G.), Dennison, E. M. (Elaine M.), de Wit, M. (Maarten), Fioravanti, A. (Antonella), Fuggle, N. R. (Nicholas R.), Haugen, I. K. (Ida K.), Herrero-Beaumont, G. (Gabriel), Honvo, G. (Germain), Laslop, A. (Andrea), Matijevic, R. (Radmila), Migliore, A. (Alberto), Mobasheri, A. (Ali), Pelletier, J.-P. (Jean-Pierre), Prieto Yerro, M. C. (María Concepción), Radermecker, R. P. (Régis Pierre), Rannou, F. (François), Rizzoli, R. (René), and Reginster, J.-Y. (Jean-Yves)

Abstract

Knee osteoarthritis (OA) is one of the most common and disabling medical conditions. In the case of moderate to severe pain, a single intervention may not be sufficient to allay symptoms and improve quality of life. Examples include first-line, background therapy with symptomatic slow-acting drugs for OA (SYSADOAs) or non-steroidal anti-inflammatory drugs (NSAIDs). Therefore, the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) performed a review of a multimodal/multicomponent approach for knee OA therapy. This strategy is a particularly appropriate solution for the management of patients affected by knee OA, including those with pain and dysfunction reaching various thresholds at the different joints. The multimodal/multicomponent approach should be based, firstly, on different combinations of non-pharmacological and pharmacological interventions. Potential pharmacological combinations include SYSADOAs and NSAIDs, NSAIDs and weak opioids, and intra-articular treatments with SYSADOAs/NSAIDs. Based on the available evidence, most combined treatments provide benefit beyond single agents for the improvement of pain and other symptoms typical of knee OA, although further high-quality studies are required. In this work, we have therefore provided new, patient-centered perspectives for the management of knee OA, based on the concept that a multimodal, multicomponent, multidisciplinary approach, applied not only to non-pharmacological treatments but also to a combination of the currently available pharmacological options, will better meet the needs and expectations of patients with knee OA, who may present with various phenotypes and trajectories.

Published
2022

29. Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study

Author

Gregson, C. L., Dennison, E. M., Compston, J. E., Adami, S., Adachi, J. D., Anderson, Jr, F. A., Boonen, S., Chapurlat, R., Díez-Pérez, A., Greenspan, S. L., Hooven, F. H., LaCroix, A. Z., Nieves, J. W., Netelenbos, J. C., Pfeilschifter, J., Rossini, M., Roux, C., Saag, K. G., Silverman, S., Siris, E. S., Watts, N. B., Wyman, A., Cooper, C., and for the GLOW Investigators

Published
2014
Full Text
View/download PDF

40. Bone densitometry worldwide : A global survey by the ISCD and IOF

Author

Clynes, M. A., Westbury, L. D., Dennison, E. M., Kanis, J., Javaid, M. K., Harvey, N. C., Fujita, M., Cooper, C., Leslie, W. D., Shuhart, C. R., The International Society for Clinical Densitometry (ISCD), and The International Osteoporosis Foundation (IOF)

Subjects
0301 basic medicine, musculoskeletal diseases, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, media_common.quotation_subject, Best practice, Osteoporosis, 030209 endocrinology & metabolism, Article, 03 medical and health sciences, Fractures, Bone, 0302 clinical medicine, Absorptiometry, Photon, Bone Density, Surveys and Questionnaires, medicine, Humans, Quality (business), fracture liaison services, Dual-energy X-ray absorptiometry, Accreditation, media_common, Service (business), medicine.diagnostic_test, business.industry, musculoskeletal, neural, and ocular physiology, bone densitometry, medicine.disease, musculoskeletal system, osteoporosis, Family medicine, epidemiology, 030101 anatomy & morphology, business, Quality assurance, human activities, dual-energy X-ray absorptiometry, quality standards
Abstract

Summary: In a global survey of fracture liaison services, most reported that DXA access met needs. However, adherence to basic DXA quality and reporting procedures was confirmed by only around 50% of institutions and many required education for operators/interpreters. Overall, there is significant variability in the access to, and quality of, DXA services worldwide. Introduction: While the use of dual-energy X-ray absorptiometry (DXA) has been widely adopted worldwide for the assessment of bone mineral density, the quality of DXA facilities is unknown. To address this, a global survey of fracture liaison services (FLS) was conducted by the International Society for Clinical Densitometry (ISCD) and the International Osteoporosis Foundation (IOF) to assess the quality of their DXA facilities. Methods: A questionnaire for the accessibility and quality of DXA services was co-created by representatives of the ISCD and the IOF and made available to institutions who participated in the Capture the Fracture Best Practice Framework. From a list of 331 contacted invitees, 124 FLS centres responded; analyses were based on 121 centres with suitable data. Results: Over 70% of institutions reported that, for over 90% of the time, DXA access met service needs, and the scanning/reporting quality was perceived as excellent. However, 25% of DXA facilities reported not being accredited by a professional/governmental organization, and adherence to some basic DXA quality assurance and reporting procedures was confirmed by < 50% of services. Importantly, in excess of 50% of institutions stated that they desired ongoing education in osteoporosis and DXA for operators and interpreters. Conclusion: There is significant variability in the access to and quality of DXA services for established FLS worldwide. Despite two decades of training initiatives in osteoporosis densitometry, many centres are falling short of the standards of the IOF-ISCD Osteoporosis Essentials criteria.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results